Answer
Pazopanib hydrochloride inhibits vascular endothelial growth factor receptors VEGFR-1, VEGFR-2 and VEGFR-3, platelet-derived growth factor receptors PDGFR-α and PDGFR-β, and stem cell factor receptor c-KIT.
Sources for this answer
- Votrient 200 mg and 400 mg film coated tabletsNovartis Pharmaceuticals UK Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 36Document updated
Sources checked